首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Challenges Faced During eCTD and CTD Filling Procedures for USFDA and Canada
【24h】

Challenges Faced During eCTD and CTD Filling Procedures for USFDA and Canada

机译:USFDA和加拿大的eCTD和CTD填充程序中面临的挑战

获取原文
           

摘要

Electronic Common Technical Document (eCTD) is a topic of increasing interest in the pharmaceutical Industry as it become compulsory for filing procedures. The?Common Technical Document?(CTD) is a set of specification for application dossier, for the registration of Medicines and designed to be used across?Europe,?Japan?and the?United States.Quality, Safety and Efficacy information is assembled in a common format?through CTD?.The CTD is maintained by the?International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use?(ICH). Electronic common technical document is an interface used by applicants of marketing authorisation for medical products to submit regulatory affairs document to the agency concerned. The purpose of this article is to present a concise overview of challenges faced during eCTD & CTD submissions in United States and Canada. A regulatory process, by which a person/organization/ sponsor/innovator gets authorization to launch a drug in the market, is known as registration process. The registration process will be done by submitting technical information to the authority.
机译:电子共同技术文件(eCTD)是制药行业越来越感兴趣的主题,因为它成为归档程序的强制性文件。 “通用技术文件”(CTD)是一套用于药品注册的申请文件规范,旨在在欧洲,日本和美国范围内使用。质量,安全性和有效性信息汇总于CTD由“统一人类使用药品注册技术要求国际会议”(ICH)维护。电子通用技术文件是医学产品的销售授权申请人所使用的接口,用于向有关机构提交法规事务文件。本文的目的是简要概述在美国和加拿大提交eCTD和CTD期间面临的挑战。个人/组织/发起人/创新者通过授权才能在市场上投放药物的监管过程称为注册过程。注册过程将通过向主管部门提交技术信息来完成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号